Skip to main content
. 2018 Oct 2;42(6):3083–3092. doi: 10.3892/ijmm.2018.3914

Figure 4.

Figure 4

BML-111 treatment improved mortality after BLM instillation. Mice received intratracheal injection of 50 µl of saline (Sham group) or BLM 2 mg/kg (for untreated group, BML-111 group and BOC-2 group). Mice were treated intraperitoneally with the saline (for Sham group and untreated group) 1 ml or BML-111 (for BML-111 group and BOC-2 group) 1 mg/kg every other day from days 0 to 21, and BOC-2 group were given 50 µg/kg BOC-2 30 min before the addition of BML-111, and monitored daily for survival. Data are analyzed by Kaplan-Meier method (n=10 for the Sham group and n=22 for the others). *P<0.05 compared to the untreated group. BOC-2, N-tert- butyloxy-carbonyl-phenyalanine-le-ucyl-phenyalanine-leucyl-phenyalanine.